← FDA Drug Approvals (Drugs@FDA)

LOPINAVIR; RITONAVIR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMA · Approved 2011-06-08

Drug application

FDA Application #

ANDA091202

Application type

Abbreviated New Drug Application (Generic)

Brand name

LOPINAVIR; RITONAVIR

Generic name

Lopinavir

Active ingredients

LOPINAVIR; RITONAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MYLAN PHARMA

First approval

2011-06-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown